A Aralex Aachen research explorer

September 14, 2020 article Open access

Cost-effectiveness analysis comparing companion diagnostic tests for EGFR, ALK, and ROS1 versus next-generation sequencing (NGS) in advanced adenocarcinoma lung cancer patients

DOI: 10.1186/s12885-020-07240-2 Full text (OA) OpenAlex

Authors 0

Author list not loaded yet.

Cited by 1 stored of 53

Cost-Effectiveness of Parallel Versus Sequential Testing of Genetic Aberrations for Stage IV Non–Small-Cell Lung Cancer in the Netherlands
2022 JCO Precision Oncology article Medicine Lung Cancer Treatments and Mutations Open access

39

citations

1 result

References 0